Sabra Healthcare REIT Holds Annual Stockholders Meeting

Sabra Healthcare REIT ( (SBRA) ) just unveiled an update.

On June 12, 2025, Sabra Healthcare REIT held its annual stockholders meeting where several key decisions were made. The stockholders elected seven directors to the board, ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for 2025, and approved the executive compensation plan, reflecting continued confidence in the company’s leadership and strategic direction.

The most recent analyst rating on (SBRA) stock is a Hold with a $16.00 price target. To see the full list of analyst forecasts on Sabra Healthcare REIT stock, see the SBRA Stock Forecast page.

Spark’s Take on SBRA Stock

According to Spark, TipRanks’ AI Analyst, SBRA is a Outperform.

Sabra Healthcare REIT’s strong financial performance and strategic growth initiatives are major strengths, supported by positive earnings call sentiment and corporate events. While technical indicators are neutral and valuation is relatively high, the solid dividend yield and liquidity position enhance the investment appeal.

To see Spark’s full report on SBRA stock, click here.

More about Sabra Healthcare REIT

Sabra Healthcare REIT operates within the healthcare real estate investment trust (REIT) industry, focusing on acquiring, financing, and owning real estate properties leased to healthcare operators.

Average Trading Volume: 2,605,531

Technical Sentiment Signal: Strong Buy

Current Market Cap: $4.29B

For detailed information about SBRA stock, go to TipRanks’ Stock Analysis page.